S036 Hair Disorders Made Easier
DESCRIPTION
This session will present a practical approach to hair disorders focused on the key differential diagnosis and types of therapy.
LEARNING OBJECTIVES
Evaluate scarring alopecia
Evaluate nonscarring alopecia
Treat scarring alopecia
SCHEDULE
1:00 PM
Getting the most from your alopecia pathology reports
Lynne J. Goldberg, MD, FAAD
1:20 PM
Diagnosis of non-scarring hair loss by trichoscopy
Rodrigo Pirmez, MD
1:45 PM
Tips on evaluation and diagnosis of scarring alopecia
Melissa Piliang, MD, FAAD
2:10 PM
Treatment and follow-up of non-scarring alopecia
Jerry Shapiro, MD, FAAD
2:35 PM
Pearls in the management of scarring alopecia
Maryanne Makredes Senna, MD, FAAD
3:00 PM
Styling tricks and helpful tips for ethnic hair loss
Yolanda M Lenzy, MD, FAAD
3:25 PM
Surgical and alternative treatments for alopecia
Meena Kumari Singh, MD, FAAD
3:50 PM
Questions and Answers
DIRECTOR
Maryanne Makredes Senna, MD, FAAD
SPEAKERS
Lynne J. Goldberg, MD, FAAD
Yolanda M Lenzy, MD, FAAD
Melissa Piliang, MD, FAAD
Rodrigo Pirmez, MD
Jerry Shapiro, MD, FAAD
Meena Kumari Singh, MD, FAAD
HANDOUTS
DISCLOSURES
Lynne J. Goldberg, MD, FAAD
UpToDate, Inc – Other(Fees);
Yolanda M Lenzy, MD, FAAD
CeraVe/Valeante – Other(Fees); Neutrogena – Consultant (1099 relationship)(Grants/Research Funding);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees); GLife – Advisory Board(Stock Options); Inmagene – Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Priovant Therapeutics – Advisory Board(Fees), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Veradermics – Advisory Board(Fees), Advisory Board(Stock);
Melissa Piliang, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(No Compensation Received); Eli Lilly and Company – Investigator(No Compensation Received), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(No Compensation Received), Speaker(Honoraria); Procter & Gamble Company – Consultant(Honoraria); Sanofi – Investigator(No Compensation Received);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); FotoFinder Systems GmbH – Speaker(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); DS Laboratories – Consultant (1099 relationship)(Honoraria); Eirion Therapeutics – Consultant (1099 relationship)(Stock Options); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Veradermics – Consultant (1099 relationship)(Fees), Stockholder Public Company(No Compensation Received);
Meena Kumari Singh, MD, FAAD
AbbVie – Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Eli Lilly – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Veradermics – Consultant (1099 relationship)(Honoraria);